FUJIAN HAIXI PHARMACEUTICALS CO., LTD. - H SHARES
(HKEX: 2637)
Fujian Haixi New Drug Creation Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It offers generic drugs for digestive, cardiovascular, endocrine, nervous, and inflammation therapeutic areas. The company was founded by Xin Shan Kang and Yan Feng on March 27, 2012 and is headquartered in Fuzhou, China.
236.600 -
-1.400
(-0.59%)
Range
213.200 - 238.000
(11.63%)
Open
235.000
Previous Close
238.000
Bid Price
234.200
Bid Volume
('000)
8.8
Ask Price
236.600
Ask Volume
('000)
0.6
Volume
('000)
339.7
Value
76,001,933
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
